Avicenna Society

Avicenna Society Educational page for neurosurgeons, spine surgeons, students, and residents.

Share real patient cases (with consent) to foster learning, collaboration, and advancement in spine surgery. The Avicenna Society is an international network for neurosurgeons, spine surgeons, students, and residents. This educational page features real patient data (shared with full patient consent for education and research) to foster open discussion, experience exchange, and dynamic learning for all involved. Our mission is to advance the art and science of spine surgery through collaboration, mentorship, and sharing both successes and challenges to improve patient outcomes. Join the Society: https://avicennatech.org/avicenna-spine-society/login-register/
Join the WhatsApp Group: https://chat.whatsapp.com/IxYLOotkWtr2Er7Rh0kVka

Looking forward to seeing you all in Dubai on January 1 at this fantastic venue. It’s going to be an incredible start to...
11/10/2025

Looking forward to seeing you all in Dubai on January 1 at this fantastic venue. It’s going to be an incredible start to the year filled with innovation, collaboration, and new milestones in spine surgery.

11/06/2025
We had a very productive discussion about **surgery cancellation criteria in spine cases**, especially concerning **anti...
11/03/2025

We had a very productive discussion about **surgery cancellation criteria in spine cases**, especially concerning **anticoagulants** and **GLP-1 receptor agonists**.
Sharing here a few key papers that summarize current recommendations and perioperative considerations.
Special thanks to **Dr. Stainer** for providing these valuable resources.

Patient underwent L3-5 OLLIF in 2023 with excellent recovery. Over the past year, developed isolated low back pain consi...
10/23/2025

Patient underwent L3-5 OLLIF in 2023 with excellent recovery. Over the past year, developed isolated low back pain consistent with sacroiliac (SI) joint pathology. SI provocation tests positive; two diagnostic/therapeutic injections each produced >80% pain relief, currently asymptomatic.

Interestingly, recent CT/MRI demonstrate significant L3-4 adjacent segment degeneration with disc herniation, yet the patient has no claudication or radiculopathy.

Question for discussion: In a case like this—radiographically severe adjacent segment disease but clinically silent and with proven SI etiology—how aggressive should one be in addressing the L3-4 disc pathology?

For those interested, here are the AP and lateral X-rays of a two-level OLLIF. These surgeries can be highly efficient, ...
10/16/2025

For those interested, here are the AP and lateral X-rays of a two-level OLLIF. These surgeries can be highly efficient, and that efficiency depends more on technique and experience

Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube.

75-year-old patient, 90% axial back pain with mild bilateral foot numbness (mostly L5). Conservative treatment has faile...
10/16/2025

75-year-old patient, 90% axial back pain with mild bilateral foot numbness (mostly L5). Conservative treatment has failed. Imaging shows notable lateral listhesis.
Question for discussion: how significant do you consider lateral listhesis in your decision-making, and which level would you prioritize for intervention in such cases?

**Taking care of high-BMI patients is one of the holy grails of spine surgery.**For years, our knee-jerk reaction has be...
10/08/2025

**Taking care of high-BMI patients is one of the holy grails of spine surgery.**
For years, our knee-jerk reaction has been to tell these patients to “lose weight first.” Unfortunately, 9 out of 10 times, immobility worsens their deconditioning, leading to cardiovascular issues far more costly than addressing the spine problem itself.

With **Trans-Kambin OLLIF**, we have reduced surgical risk to the point that we can now safely offer minimally invasive solutions even to this complex population. When performed **algorithmically and precisely**, these procedures can be both safe and efficient—this patient’s surgery lasted **48 minutes**, and they were **discharged in less than 24 hours**.

🎥 Watch the case here: [https://youtube.com/shorts/Eb1hP6-8Sn4?feature=share](https://youtube.com/shorts/Eb1hP6-8Sn4?feature=share)



https://youtube.com/shorts/Eb1hP6-8Sn4?feature=share

Intraoperative view of patient with very high BMI where the screws are actually vanished under the skin, but MIS is still a good possibility with proper tech...

Mastering the Ring Curette in TransKambin OLLIFIt is not easy to compress 15 years of experience into a five-minute vide...
10/08/2025

Mastering the Ring Curette in TransKambin OLLIFIt is not easy to compress 15 years of experience into a five-minute video, but mastering the use of the ring curette in TransKambin OLLIF is critical. This is an extraordinarily powerful tool — and with such power comes the need for precision, awareness, and technique. In this short video, I share essential insights and tips that can make all the difference in safety and outcomes.🎥 Watch here: [https://youtu.be/zKGR8456w1w](https://youtu.be/zKGR8456w1w)

https://youtu.be/zKGR8456w1w

Dr. Abbasi explains the use of OLLIF ring curate and tricks about how and how not to use it. Dr. Abbasi explains the use of OLIF ring curate and tricks about...

Proud to participate right after the World Conference of Neurosurgery in Dubai, UAE, joining a distinguished faculty to ...
09/25/2025

Proud to participate right after the World Conference of Neurosurgery in Dubai, UAE, joining a distinguished faculty to present Trans-Kambin OLLIF and sacroiliac joint fusion to colleagues from the Middle East and North Africa. Grateful to Dr. Munshi for hosting this outstanding venue and looking forward to the exchange of knowledge and collaboration.

Address

1601 Highway 13 E
Burnsville, MN
55337

Alerts

Be the first to know and let us send you an email when Avicenna Society posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram